Announcement
18 Jun 2024
In June 2024, US BARDA provided approximately USD 24 million to GeoVax Inc for a Phase 2b clinical trial of their COVID-19 vaccine candidate GEO-CM04S1 under Project NextGen.
Source
Number of interventions
1
1 certainly harmful
0 likely harmful
0 liberalising
Implementation date
18 Jun 2024
Revocation date:
No revocation date
See all
This Thread tracks harmful trade policy interventions affecting all products. Covering all types of interventions monitored by Global Trade Alert, it highlights how the yearly number of these measures has evolved over time.
Published: 04 Sep 2024
70533
194
This Thread tracks harmful trade policy interventions introduced by G7 members since 2009. It covers all types of interventions monitored by Global Trade Alert.
Published: 13 Jan 2025
25488
38
This Thread tracks harmful trade policy interventions introduced by G20 members since 2009. It covers all types of interventions monitored by Global Trade Alert.
Published: 15 Jan 2025
53913
121
This Thread tracks harmful trade policy interventions affecting HS codes for medical consumables, equipment, medicines, vaccines, as well as chemicals used in pharmaceutical production. It covers all types of interventions monitored by Global Trade Alert since 2009. To identify relevant policy actions, the Global Trade Alert team focused on the identification of relevant HS codes following the pr...
Published: 09 Jan 2025
7344
152